SINGAPORE, May 29, 2014 — (PRNewswire) — Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced it has completed the initial design engineering for a new data processing module for its patented real-time 3D display, representing a significant milestone in bringing the display system to commercial production. The new configuration provides for real time capability, with a system capable of transferring data for up to ninety views in full High Definition. The new system design eliminates the previous requirement for ALP (accessory light modulator package) boards, allowing for a significantly cheaper and more compact design. The redesign also includes the development of 3D image compression for data interface, and a new application interface to allow direct transfer of data from existing programs such as AutoCAD. These recent developments directly support Zecotek's recent initiative in developing new 3D printers and 3D printer interfaces.
"There is a substantial latent demand for a commercially viable, glasses-free, true 3D HD system which can handle real time data from a variety of existing sources and can adapt to either small workstations or large venue screens." said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "The new design represents a significant cost and performance breakthrough for our patented 3D display technology and importantly provides a core technology to both front or rear projection displays, where we have also overcome the technical barriers associated with early designs, which relied on an electromechanical interface."
Zecotek has received patent allowances from the United States, Europe and Eurasia covering the 3D/2D switchable optical imaging system of Zecotek's 3D Display. The 3D/2D switchable optical imaging system further improves the core capabilities of the 3D display technology by introducing a software-selectable full-resolution 2D mode with viewing angles and dynamic range/colour depth on par with conventional 2D displays. The patent also covers technology for both 3D and 2D modes, dynamic adjustment of viewing angle, number and width of viewing zones as well as the functionality to dynamically control the positioning of different viewing zones.
Patents have been granted to Zecotek for its 3D display system in the United States, China, Europe, Eurasia, Russia and Australia. Other patents have been filed and are pending in Japan, Korea and India.
About Zecotek's 3D Display System
Zecotek's 3D Display System is based on the auto-stereoscopic principle, but with substantial innovative and patented improvements and represents a new and unique generation of 3D displays. It has the capability of simultaneously presenting 3D and 2D images on the same screen, and for separate views at different viewing angles. Zecotek's true, auto-stereoscopic 3D2D display system requires no eyewear and has an effective viewing angle of 40 degrees with 90 concurrent perspectives allowing for multiple views at the same time. Another unique feature of the Zecotek system is constant motion parallax within the viewing angle. Motion parallax eliminates the sense of imbalance and dizziness during normal observation which can occur with polarized and shutter glasses used with other commercial systems. Furthermore Zecotek's 3D display features the preservation of the base resolution in every perspective view irrespective of the number of such views. This is not true for any other glasses-free displays where the base resolution is divided by the number of views. Zecotek's white paper on 3D display technology is available on
www.zecotek.com.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center (South Korea). For more information visit
www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at
www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors - mining, oil & gas, technology & life sciences, diversified industries and clean technology - based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
Image with caption: "Zecotek - Leading the Way in Photonics (CNW Group/Zecotek Photonics Inc.)". Image available at: http://photos.newswire.ca/images/download/20140529_C7463_PHOTO_EN_40876.jpg
